Journal of Clinical Oncology (JCO) Podcast

The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results publ

Episodes

Total: 417

This podcast discusses approaches to risk assessment of contralateral breast cancer and factors whic

Amongst several different liver directed therapy approaches, chemoembolization (called TACE) and rad

A discussion of a phase 2 trial of a MEK inhibitor in patients with V600 BRAF mutations and consider

This podcast discusses therapeutic options for MDS patients including azacytidine and allogeneic ste

This video support tool describing CPR lets patients make much better informed decisions about the u

Radioimmunotherapy alone or in sequential combination with chemotherapy is effective initial treatme

Whole-brain radiation therapy of metastases to the brain is not innocuous - it is associated with de

This is a commentary on the role of MET in cancer using Choueri et al as an example of rationale the

A discussion of treatment approaches for newly diagnosed aggressive AIDS-related lymphomas

Seven year follow up of B-31 demonstrates a striking and reassuring lack of longer-term cardiac even

More adjuvant chemotherapy is not always better for early breast cancer patients - Discussion and co

The podcast reviews the evolution of staging and treatment of Hodgkin lymphoma, reducing the toxicit

In this podcast, Attar and colleagues explore whether patients aged 60-75 who enter remission with b

This podcast will review a JCO article showing that the use of breast brachytherapy as a method of d

This Podcast provides observations and commentary about referral practices of oncologists to special

This podcast characterizes the clinical utility of the screening tests recommended by the Children’s

Publication of a large collaborative group trial appears to definitively demonstrate the safety of s

In this podcast, results of a randomized phase III clinical trial evaluating the use of Rituximab ma

Melissa Cousino and colleagues found that few parents understand the scientific purpose of phase I p

The prognostic importance of ALK-protein expression was established over a decade ago. More recent